Cel-Sci
CVM
$1.72
Share price
5.52%
Change (1 day)
-31.20%
Change (1 year)
Categories
Cel-Sci (CVM) Fails to deliver data
Key failure to deliver metrics for Cel-Sci :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.04 M
- Last 3 months FTD volume: $0.52 M
- Last year FTD volume: $5.01 M
Failures to deliver for Cel-Sci (CVM) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Cel-Sci (CVM) - since 2017
Volume in USD (price x number of shares), data since 2017Cel-Sci (CVM) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.6 M | -88.84% |
| 2023 | $5.42 M | -85.85% |
| 2022 | $38.35 M | -20.63% |
| 2021 | $48.32 M | -71.33% |
| 2020 | $0.16 B | 155.04% |
| 2019 | $66.1 M | 371.11% |
| 2018 | $14.03 M | 492.73% |
| 2017 | $2.36 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.59 B | 🇺🇸 USA |
 Amgen AMGN | $62.04 M | $0.18 B | 🇺🇸 USA |
 Xencor XNCR | $0.11 M | $2.13 M | 🇺🇸 USA |
 Curis CRIS | N/A | $1.01 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $6.83 M | $36.36 M | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | $0.12 M | $1.91 M | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.99 M | $6.57 M | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.04 M | $0.25 M | 🇺🇸 USA |